Provided by Tiger Trade Technology Pte. Ltd.

Boston Scientific

69.78
+1.632.39%
Post-market: 69.790.0100+0.01%16:22 EDT
Volume:9.44M
Turnover:655.74M
Market Cap:103.44B
PE:35.97
High:70.10
Open:69.00
Low:68.60
Close:68.15
52wk High:109.50
52wk Low:67.56
Shares:1.48B
Float Shares:1.48B
Volume Ratio:0.73
T/O Rate:0.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):1.94
EPS(LYR):1.94
ROE:12.45%
ROA:5.98%
PB:4.27
PE(LYR):35.97

Loading ...

China Merchants Initiates Boston Scientific at Buy With $88 Price Target

MT Newswires Live
·
Mar 04

Boston Scientific: Near-Term EP Reset but 2027 Growth Drivers Support Buy Rating

TIPRANKS
·
Mar 04

Penumbra Sale To Boston Scientific Puts Focus On Deal Terms And Future

Simply Wall St.
·
Mar 04

Boston Scientific Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Mar 04

American Oncology Network Partner FWMOH and Cameron Health Expand Cancer Care Access in Angola, Indiana

Reuters
·
Mar 04

Boston Scientific Corp Stock Moved Down by 3.32% on Mar 3: Facts Behind the Movement

TradingKey
·
Mar 04

Boston Scientific Exec Says There Could Be Some Disruption Depending on How Long the War Plays Out

THOMSON REUTERS
·
Mar 03

Boston Scientific Exec Says Regions Impacted by U.S.-Israel War Against Iran Bring About 1% of Revenue for Co - Conf Call

THOMSON REUTERS
·
Mar 03

Levi & Korsinsky Probes Boston Scientific for Possible Securities Fraud

Reuters
·
Mar 02

Boston Scientific Corp. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Feb 28

Boston Scientific Secures New Credit Facilities for Acquisition

TIPRANKS
·
Feb 27

Boston Scientific signs $3 billion revolving credit agreement with Wells Fargo and lenders

Reuters
·
Feb 27

Boston Scientific Corp: Under Term Loan Credit Agreement, May Borrow 364-Day Delayed Draw Term Loan of up to $5 Bln

THOMSON REUTERS
·
Feb 27

Boston Scientific Corp - Enters $2 Bln 364-Day Revolving Credit Agreement - SEC Filing

THOMSON REUTERS
·
Feb 27

Argus Lowers Boston Scientific Price Target to $115 From $130

MT Newswires Live
·
Feb 27

Boston Scientific Halts Use Of Select Stent Delivery Devices After Patient Deaths

Benzinga
·
Feb 27

Penumbra Seen as 'Strategic and Financial Fit' for Boston Scientific, RBC Says

MT Newswires Live
·
Feb 27

BRIEF-FDA Boston Scientific Removes Certain Axios Stents And Electrocautery-Enhanced Delivery Systems

Reuters
·
Feb 26

FDA: as of Dec 23, Boston Scientific Has Reported 167 Serious Injuries, and Three Deaths Associated With Stent Issue

THOMSON REUTERS
·
Feb 26

Hold Rating Maintained on Penumbra Amid Strong Results but Limited Visibility Ahead of Boston Scientific Acquisition

TIPRANKS
·
Feb 26